Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- AKYA
- Price
- 1.17
- Stock movement down
- -0.05 (-4.10%)
- Company name
- Akoya Biosciences Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Instruments & Supplies
- Market cap
- 57.99M
- Ent value
- 161.77M
- Price/Sales
- 0.67
- Price/Book
- 4.25
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -72.98%
- 3 year return
- -52.40%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-04
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
AKYA does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.67 |
| Price to Book | 4.25 |
| EV to Sales | 1.86 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 49.56M |
| EPS (TTM) | -1.17 |
| FCF per share (TTM) | -0.98 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 86.81M |
| Gross profit (TTM) | 48.23M |
| Operating income (TTM) | -45.29M |
| Net income (TTM) | -57.97M |
| EPS (TTM) | -1.17 |
| EPS (1y forward) | -0.62 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 55.56% |
| Operating margin (TTM) | -52.17% |
| Profit margin (TTM) | -66.77% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 12.56M |
| Net receivables | 12.79M |
| Total current assets | 76.86M |
| Goodwill | 18.26M |
| Intangible assets | 15.27M |
| Property, plant and equipment | 0.00 |
| Total assets | 129.97M |
| Accounts payable | 8.76M |
| Short/Current long term debt | 84.92M |
| Total current liabilities | 27.99M |
| Total liabilities | 116.34M |
| Shareholder's equity | 13.63M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -46.67M |
| Capital expenditures (TTM) | 2.01M |
| Free cash flow (TTM) | -48.68M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -425.20% |
| Return on Assets | -44.60% |
| Return on Invested Capital | -334.88% |
| Cash Return on Invested Capital | -281.22% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.19 |
| Daily high | 1.20 |
| Daily low | 1.07 |
| Daily Volume | 162K |
| All-time high | 26.05 |
| 1y analyst estimate | 3.50 |
| Beta | 1.35 |
| EPS (TTM) | -1.17 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 12 May 2025 |
Downside potential
Loading...
Downside potential data
| AKYA | S&P500 | |
| Current price drop from All-time high | -95.51% | -17.56% |
| Highest price drop | -95.51% | -56.47% |
| Date of highest drop | 4 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -66.74% | -11.07% |
| Avg time to new high | 999 days | 12 days |
| Max time to new high | 998 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
57.99M
Marketcap category
Small-cap
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Employees
330
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page